| Literature DB >> 31214259 |
Maria Teresa Congedo1,2, Roberto Iezzi2,3, Dania Nachira1,2, Anna Rita Larici2,3, Marco Chiappetta1,2, Lucio Calandriello2,3, Maria Letizia Vita1,2, Elisa Meacci1,2, Venanzio Porziella1,2, Mahmoud Ismail4, Riccardo Manfredi2,3, Stefano Margaritora1,2.
Abstract
BACKGROUNDS: Although uniportal video-assisted thoracic surgery (VATS) theoretically allows the direct palpation of any zone of the lung through a small incision, sometimes it can be difficult to localize pure ground-glass opacities anyway. The aim of this study is to evaluate the usefulness and safety of preoperative computed tomography (CT)-guided microcoil localization of GGO nodules in patients undergoing uniportal VATS lung resection.Entities:
Year: 2019 PMID: 31214259 PMCID: PMC6535831 DOI: 10.1155/2019/5383086
Source DB: PubMed Journal: J Oncol ISSN: 1687-8450 Impact factor: 4.375
Figure 1CT-images showing nodule localization by microcoil in different scanning planes.
Figure 2Radiological (a) and intraoperative (b) view of the microcoil deployed partially inside the nodule and partially along the visceral pleura.
Figure 3Appearance of the microcoil (yellow arrow) inside the specimen sectioned by the pathologist (blue arrows indicate the nodule sectioned).
Characteristics of GGO nodules.
| Characteristics of nodules | |
|---|---|
| Pure/ subsolid | 11 (36.7%)/19 (63.3%) |
|
| |
| Total diameter (mm) | 15.53±6.72 |
|
| |
| Distance (lesion - parietal pleura) (mm) | 20.00 ± 12.68 |
|
| |
| Lobe | |
| Right | |
| Upper | 10 (33.3%) |
| Medium | 2 (6.6%) |
| Lower | 5 (16.7%) |
| Left | |
| Upper | 9 (30%) |
| Lower | 4 (13.4%) |
|
| |
| Type of resection | |
| Wedge resection | 19 (63.3%) |
| Segmentectomy | 4 (13.3%) |
| Wedge resection + Completion lobectomy | 7 (23.4%) |
Final pathological characteristics of nodules.
| Pathology | 30 (%) |
|---|---|
| Preinvasive lesions | |
| Atypical Adenomatous Hyperplasia | 3 (10%) |
| Adenocarcinoma in situ ( | 2 (6.7%) |
|
| |
| Minimally invasive lesions | |
| Minimally invasive adenocarcinoma (MIA) | 4 (13.3%) |
| Invasive adenocarcinoma | 17 (56.7%) |
|
| |
| Other | |
| Fibrosis | 4 (13.3%) |